A Study of Panobinostat in Pediatric Patients With Solid Tumors Including MRT/ATRT

Clinical trial NCT04897880 · TERMINATED

Trial details

NCT number: NCT04897880
Sponsor: Australian & New Zealand Children's Haematology/Oncology Group
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Rhabdoid Tumor Atypical Teratoid/Rhabdoid Tumor Malignant Rhabdoid Tumor Recurrent Brain Tumor, Childhood

Start date: 2019-01-09
Primary completion: 2024-05-08
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.